Journal
CANCER LETTERS
Volume 313, Issue 2, Pages 211-217Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2011.09.006
Keywords
mTORC1; STAT3; PTEN; TSC; Benign tumor
Categories
Funding
- National Natural Science Foundation of China [30788004, 30872840, 30971503]
- National Basic Research Program of China (973 Program) [2009CB522203]
- Anhui Medical University [0108026101, 0108026201]
Ask authors/readers for more resources
Aberrant activation of mammalian target of rapamycin complex 1 (mTORC1), caused by loss or inactivation of TSC1/TSC2 protein complex, leads to negative feedback inhibition of Akt. The exact mechanisms of this process are still not fully understood. Here we present evidence for the involvement of STAT3, a known mTORC1 regulated transcription factor, in this process. We demonstrate that STAT3 promotes the transcription of PTEN by directly binding on the PTEN promoter. Elevated PTEN then inhibits the proliferation of Tsc1(-/-) Tsc2(-/-) cells through down-regulation of Akt signaling. Activation of PTEN in this pathway may thus serve as a protective mechanism against hyper-activated mTORC1 mediated tumorigenesis and contribute to the benign nature of tumors caused by loss of either TSC1 or TSC2. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available